Genomic profiling and predicting treatment response in acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genomic profiling and predicting treatment response in acute myeloid leukemia

Published:2019-05 Issue:7 Volume:20 Page:467-470
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Isidori Alessandro¹,Loscocco Federica¹,Curti Antonio²,Amadori Sergio³,Visani Giuseppe¹

Affiliation:

1. Hematology & Hematopoietic Stem Cell Transplant Center, AORMN, Pesaro, Italy

2. Department of Experimental, Diagnostic & Specialty Medicine, Institute of Hematology ‘L&A Seràgnoli’, University of Bologna, Bologna, Italy

3. GIMEMA Foundation, 00187 Rome, Italy

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2018-0202

Reference20 articles.

1. Gene expression profiling in MDS and AML: potential and future avenues

2. Acute Myeloid Leukemia

3. Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients

4. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

5. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological p38 MAPK inhibitor SB203580 enhances AML stem cell line KG1a chemosensitivity to daunorubicin by promoting late apoptosis, cell growth arrest in S-phase, and miR-328-3p upregulation;Saudi Pharmaceutical Journal;2024-06

2. Effect of lncRNA XIST on acute myeloid leukemia cells via miR-142-5p-PFKP axis;Hematology;2024-02-02

3. Expressions of TGF-β1 and VEGF in patients with acute myeloid leukemia and associations with prognosis;Revista Romana de Medicina de Laborator;2022-07-01

4. Immunotherapy in Acute Myeloid Leukemia: Where We Stand;Frontiers in Oncology;2021-05-10

5. Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML;Blood Advances;2020-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3